Match. Apply. Get paid. The simplest way to participate in paid clinical research.

Compensation is for time and inconvenience, not income.

Arctuva

Browse Studies About FAQ

Arctuva

Match. Apply. Get paid. The simplest way to participate in paid clinical research.

Product

Browse Studies How it Works Verification Arctuva Pro For Sponsors

Company

About Contact FAQ

Legal

Privacy Terms of Service Security Accessibility Transparency Report

Compensation is for time and inconvenience, not income.

Browse Studies — Arctuva | Arctuva

Browse studies

Find your next paid study

3 recruiting studies matching your filters

Newest first Highest paying

Filters

Condition

Location

Phase

Min compensation ($)

Max compensation ($)

Prospective Clinical Assessment Study in Children With Hypochondroplasia: ACCEL

This is a long-term, multicenter, non-interventional study of children ages 2.5 to \<17 years with hypochondroplasia (HCH).

Hypochondroplasia

~Estimated

~$10 – $1,050

QED Therapeutics, a BridgeBio companyNCT06410976

A Multicenter Multinational Observational Study of Children With Hypochondroplasia

This study will assess growth over time and the clinical course of HCH in children by collecting growth measurements and other variables of interest.

Hypochondroplasia

~Estimated

~$10 – $1,050

BioMarin PharmaceuticalNCT06212947

Phase 2

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Vosoritide in Infants and Young Children With Hypochondroplasia, Aged 0 to < 36 Months

The purpose of this study is to evaluate the safety and efficacy of daily administration of vosoritide in participants with HCH aged 0 to \< 36 months over a 5…

Hypochondroplasia

~Estimated

~$10 – $8,750

BioMarin PharmaceuticalNCT07126262